Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
BioLite, Inc.
BioLite, Inc.
Shanghai Henlius Biotech
Radiopharm Theranostics, Ltd
IntoCell, Inc
Onchilles Pharma Inc
OncoHost Ltd.
Tianjin ConjuStar Biologics Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd.
JenKem Technology Co., Ltd.
Mabpro, a.s.
Power Life Sciences Inc.
Shanghai Henlius Biotech